Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, placebo-controlled, double-blind study of two topical products for psoriasis
2009-012855-90Phase 3Completed
- Sponsor
- Jelfa
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betamethasone dipropionate + salicylic acid in plaque psoriasis (3 arms), sponsored by Jelfa. Primary endpoint: Psoriasis Area and Severity Index (PASI) score. Started Jun 2009; status: completed.
02
Drugs
betamethasone dipropionate + salicylic acid
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2009-012855-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012855-90.